Concluding remarks

Description

In this final session the audience asks questions to the lecturers, specifically about prostate cancer, how to deal with hematocrit elevations, and speculation about the temporary initial increase in cardiovascular risk seen in some studies.


 

Speakers

Dr. Stefan Arver

Dr. Stefan Arver